PPD

When drug developers choose the right outsourcing strategies in clinical research, they can gain significant benefits in terms of quality, efficiency, and operational success. In its third annual Functional Service Provider (FSP) Trends Report, Thermo Fisher Scientific’s clinical research business—PPD—gathered insights from 150 global biotech and pharma leaders to determine how FSP models help sponsors address common industry obstacles.

Developing therapies and successfully executing clinical trials for rare ophthalmologic disorders present unique challenges, but with these challenges come significant opportunities to employ innovative strategies to drive success. Explore how careful feasibility and novel approaches to patient recruitment can advance the treatment of rare conditions of the eye. Live: Friday, 27 Oct., 2017 | 11 am EDT | 8 am PDT | 1600 BST | 1700 CEST / On Demand available after airing until 27 Oct., 2018. Register free: http://www.appliedclinicaltrialsonline.com/act_w/success